PL369201A1 - Bakterie wytwarzające kwas mlekowy do stosowania jako organizmy probiotyczne w ludzkiej pochwie - Google Patents

Bakterie wytwarzające kwas mlekowy do stosowania jako organizmy probiotyczne w ludzkiej pochwie

Info

Publication number
PL369201A1
PL369201A1 PL02369201A PL36920102A PL369201A1 PL 369201 A1 PL369201 A1 PL 369201A1 PL 02369201 A PL02369201 A PL 02369201A PL 36920102 A PL36920102 A PL 36920102A PL 369201 A1 PL369201 A1 PL 369201A1
Authority
PL
Poland
Prior art keywords
lactic acid
bacterial strains
producing bacteria
acid producing
human vagina
Prior art date
Application number
PL02369201A
Other languages
English (en)
Other versions
PL206760B1 (pl
Inventor
Carolina Samuelsson
Endre Kvanta
Jiffer Anna Weiner
Original Assignee
Ellen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20285385&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL369201(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ellen Ab filed Critical Ellen Ab
Publication of PL369201A1 publication Critical patent/PL369201A1/pl
Publication of PL206760B1 publication Critical patent/PL206760B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL369201A 2001-09-20 2002-09-19 Wyizolowany szczep bakteryjny, sposób izolowania szczepu bakteryjnego, kompozycja i artykuł sanitarny do profilaktyki i/lub leczenia infekcji przewodu moczowo-płciowego oraz zastosowanie takiego szczepu PL206760B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103127A SE521022C2 (sv) 2001-09-20 2001-09-20 Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa

Publications (2)

Publication Number Publication Date
PL369201A1 true PL369201A1 (pl) 2005-04-18
PL206760B1 PL206760B1 (pl) 2010-09-30

Family

ID=20285385

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369201A PL206760B1 (pl) 2001-09-20 2002-09-19 Wyizolowany szczep bakteryjny, sposób izolowania szczepu bakteryjnego, kompozycja i artykuł sanitarny do profilaktyki i/lub leczenia infekcji przewodu moczowo-płciowego oraz zastosowanie takiego szczepu

Country Status (14)

Country Link
US (2) US7312067B2 (pl)
EP (1) EP1427808B2 (pl)
JP (1) JP4223955B2 (pl)
CN (1) CN1308436C (pl)
AT (1) ATE393211T2 (pl)
AU (1) AU2002343282B2 (pl)
CA (1) CA2459178C (pl)
DE (1) DE60226254T3 (pl)
ES (1) ES2305313T5 (pl)
IL (2) IL160937A0 (pl)
PL (1) PL206760B1 (pl)
SE (1) SE521022C2 (pl)
WO (1) WO2003038068A1 (pl)
ZA (1) ZA200401315B (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
SE526029C2 (sv) * 2003-05-13 2005-06-21 Sca Hygiene Prod Ab Hygien produkt innefattande bakteriepreparation och förfarande för dess framställning
EP1633378A2 (en) * 2003-06-13 2006-03-15 N.V. Nutricia Pediocin-producing pediococci
SI1506781T1 (pl) * 2003-11-03 2005-08-31 Volkmann Peter Hansen
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
EP1802318A1 (en) * 2004-10-22 2007-07-04 Medinova AG Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
EP1962774B1 (en) * 2005-11-01 2014-01-01 Mount Sinai School of Medicine Growth control of oral and superficial microorganisms using gallium compounds
CN101657221A (zh) 2006-11-17 2010-02-24 Sca卫生用品公司 包含微生物抑制性组合物的卫生用品
CN109010900A (zh) 2006-11-17 2018-12-18 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
RU2413761C1 (ru) * 2006-11-17 2011-03-10 Ска Хайджин Продактс Аб Lactobacillus fermentum Ess-1, DSM17851, И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРОФИЛАКТИКИ КАНДИДОЗА И ИНФЕКЦИЙ МОЧЕВЫХ ПУТЕЙ
AU2006350771B2 (en) * 2006-11-17 2012-12-06 Sca Hygiene Products Ab Lactobacillus fermentum Ess-1, DSM17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
US8642029B2 (en) * 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
EP2158916A1 (en) 2008-08-27 2010-03-03 Ellen Aktiebolag Administration unit comprising lactic acid bacteria
CZ2009444A3 (cs) 2009-07-09 2010-09-01 Arko-Consult S.R.O. Prevence syndromu toxického šoku pomocí bakterií rodu Lactobacillus
US20110224637A1 (en) * 2010-02-16 2011-09-15 Playtex Products, Llc LOW pH, OPTIMAL ORP, AND ODOR-REDUCING FIBERS, A PROCESS FOR MAKING THE FIBERS, AND ARTICLES MADE THEREFROM
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN102727531A (zh) * 2012-07-23 2012-10-17 郑州金森生物科技工程有限公司 一种对阴道炎具有治疗和预防作用的活性乳酸菌胶囊
CN103074270A (zh) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 一种卷曲乳杆菌及其应用
WO2014106541A1 (en) 2013-01-04 2014-07-10 Ellen Ab Dermal composition for use in the external genital area in females
CN103911305B (zh) * 2013-01-05 2016-04-13 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN103911309B (zh) * 2013-01-05 2016-08-24 欣力菲生物医药技术（天津）有限公司 加氏乳杆菌菌株及其用途
CN103911308A (zh) * 2013-01-05 2014-07-09 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN103911306B (zh) * 2013-01-05 2016-08-24 欣力菲生物医药技术（天津）有限公司 加氏乳杆菌菌株及其用途
CN103911307B (zh) * 2013-01-05 2016-04-13 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN104630083B (zh) * 2013-11-08 2018-07-06 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇女保健产品中的应用
CZ2014565A3 (cs) 2014-08-22 2016-03-02 Vysoká škola chemicko - technologická v Praze Kmeny laktobacilů produkující látky účinné proti vaginálním patogenům, jejich použití a hygienické prostředky je obsahující
CN104694413B (zh) * 2014-11-21 2018-04-17 北京百益恒源科技有限公司 一株弯曲乳酸杆菌（Lactobacillus crispatus）及其制药用途
MX383921B (es) * 2015-06-29 2025-03-14 Ferring Bv Bacteria lactobacillus rhamnosus para el tratamiento de, por ejemplo, vaginosis bacteriana.
CN108235682A (zh) 2015-09-29 2018-06-29 金伯利-克拉克环球有限公司 用于维护微生物群落的健康平衡的协同组合物
DE102015119941A1 (de) * 2015-11-10 2017-05-11 Delphi Beteiligungsgesellschaft mbH Neuartiger Hygieneartikel
KR102769558B1 (ko) 2017-02-28 2025-02-19 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물
US20200171107A1 (en) * 2017-07-07 2020-06-04 Osel, Inc. High potency stable formulations of vaginal lactobacillus
WO2019018348A1 (en) * 2017-07-18 2019-01-24 Aobiome Llc AMMONIA-OXIDIZING MICROORGANISMS FOR UTILIZATION AND ADMINISTRATION AT THE UROGENITAL SYSTEM
CN107899059A (zh) * 2017-10-30 2018-04-13 苏州宝丽洁医疗科技有限公司 一种消炎抗菌型卫生棉条及其制备方法
IL266752B (en) 2019-05-20 2020-11-30 Shenkar Eng Design Art Fiber-based functional materials including microbial flakes, methods for their preparation and use
AU2020317501B2 (en) * 2019-07-24 2024-11-14 Asahi Group Holdings, Ltd. Agent for regulating female hormone secretion and agent for alleviating unpleasant symptoms
CN113512509B (zh) * 2021-05-07 2022-02-22 南方医科大学珠江医院 卷曲乳杆菌及其用途
CN113308405A (zh) * 2021-06-04 2021-08-27 青岛诺森生物技术有限责任公司 一种新型的双益生菌协同复合菌剂及其应用
CN113862188B (zh) * 2021-10-15 2023-06-16 广东一元兰欣生物科技有限公司 一株格氏乳杆菌ls03及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
SE9100364L (sv) 1991-02-05 1992-08-06 Bac Dev In Sweden Ab Tampong eller binda impregnerad med en kultur av levande mjoelksyrabakterier i avsikt att minska risken foer urogenitala infektioner
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
UA39965C2 (uk) 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
US6180100B1 (en) 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
CN1184637A (zh) * 1996-12-07 1998-06-17 大连医科大学科达药业有限公司 治阴道病的乳杆菌及制剂
DE19713908A1 (de) † 1997-04-04 1998-10-08 Symbio Herborn Group Gmbh & Co Vaginaltampon und Verfahren zu seiner Herstellung
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
SE519648C2 (sv) † 1998-03-06 2003-03-25 Essum Ab Ny stam av Lactobacillus plantarum
ES2165139T3 (es) * 1998-04-30 2002-03-01 Vesely Renata Maria Cavaliere Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales.
WO2000035465A2 (en) * 1998-12-11 2000-06-22 Urex Biotech Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
AU4905300A (en) † 1999-05-25 2000-12-12 Andrew W. Bruce Oral administration of lactobacillus for the maintenance of health in women
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa

Also Published As

Publication number Publication date
EP1427808A1 (en) 2004-06-16
EP1427808B2 (en) 2017-06-28
IL160937A (en) 2011-05-31
SE0103127L (sv) 2003-03-21
CA2459178A1 (en) 2003-05-08
JP2005507256A (ja) 2005-03-17
ES2305313T3 (es) 2008-11-01
AU2002343282B2 (en) 2005-10-20
DE60226254T2 (de) 2009-06-25
EP1427808B1 (en) 2008-04-23
JP4223955B2 (ja) 2009-02-12
ATE393211T2 (de) 2008-05-15
ES2305313T5 (es) 2017-11-13
CA2459178C (en) 2013-01-22
IL160937A0 (en) 2004-08-31
SE521022C2 (sv) 2003-09-23
CN1556852A (zh) 2004-12-22
US20080057046A1 (en) 2008-03-06
US7312067B2 (en) 2007-12-25
ZA200401315B (en) 2005-05-25
SE0103127D0 (sv) 2001-09-20
DE60226254T3 (de) 2017-11-16
US20040253217A1 (en) 2004-12-16
PL206760B1 (pl) 2010-09-30
HK1070385A1 (en) 2005-06-17
DE60226254D1 (de) 2008-06-05
WO2003038068A1 (en) 2003-05-08
CN1308436C (zh) 2007-04-04

Similar Documents

Publication Publication Date Title
IL160937A0 (en) Lactic acid producing bacteria for use as a probiotic organisms in the human vagina
JP3993168B2 (ja) ラクトバシルス・ペントサス株を含む組成物およびそれらの使用
JP6509822B2 (ja) 細菌性腟症の予防的および／または治療的処置に使用するための乳酸菌含有組成物
KR102146146B1 (ko) 프로바이오틱으로서 락토바실러스 펜토수스의 균주
RU2004130876A (ru) Штаммы lactobacillus
WO2000010582A3 (en) Probiotic, lactic acid-producing bacteria and uses thereof
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
WO2000071138A3 (en) Oral administration of lactobacillus for the maintenance of health in women
WO2001058465A3 (en) Probiotic therapy for newborns
AU2018282018B2 (en) Compositions and methods for reducing flatulence
CO4830476A1 (es) Nuevo agente
CA2490896A1 (en) Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
JP2010509982A (ja) 微生物阻害組成物を含む衛生用品
PL1622652T3 (pl) Produkt higieniczny zawierający kompozycję probiotyczną
TW201316996A (zh) 抑制陰道炎病原菌之乳酸桿菌及其用途
WO2004060272A3 (en) Delivery of peroxide-generating enzymes to the vaginal tract
SE9800749D0 (sv) New agent
Chakoosari Probiotics for prevention of Candida Infections
CN103142814A (zh) 一种女用益生菌滋养剂

Legal Events

Date Code Title Description
RECP Rectifications of patent specification